BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18090139)

  • 1. Update on drug-eluting stents.
    Sims JM
    Dimens Crit Care Nurs; 2007; 26(6):237-40. PubMed ID: 18090139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three years since the FDA advisory panel on drug-eluting stents: what have we learned about off-label use and stent thrombosis?
    Naidu SS
    J Invasive Cardiol; 2010 Jan; 22(1):20-1. PubMed ID: 20048394
    [No Abstract]   [Full Text] [Related]  

  • 3. Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.
    Kandzari DE; Farb A; Boam AB
    Circ Cardiovasc Interv; 2009 Dec; 2(6):574-9. PubMed ID: 20031776
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary stents: current status.
    Garg S; Serruys PW
    J Am Coll Cardiol; 2010 Aug; 56(10 Suppl):S1-42. PubMed ID: 20797502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stent fracture and acute coronary syndrome.
    Chhatriwalla AK; Cam A; Unzek S; Bhatt DL; Raymond RE; Lincoff AM; Whitlow PL; Ellis SG; Tuzcu EM; Kapadia SR
    Cardiovasc Revasc Med; 2009; 10(3):166-71. PubMed ID: 19595398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mounting evidence for safety and improved outcomes of drug-eluting stenting: but is it the stent?
    King SB; Hannan EL
    Circulation; 2008 Oct; 118(18):1783-4. PubMed ID: 18852362
    [No Abstract]   [Full Text] [Related]  

  • 8. Very late thrombosis of drug-eluting stents: a brief literature review and case example.
    Agarwal SK; Shawl F; Raman VK; Binbrek AS
    J Invasive Cardiol; 2008 Dec; 20(12):655-8. PubMed ID: 19057030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of implantation of multiple drug-eluting stents].
    Fu Q; Li ZL; Wu HC
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):110-2. PubMed ID: 18227039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of early discontinuation of dual-antiplatelet therapy: room for improvement.
    Jarvie JL; Foody JM
    Circulation; 2010 Sep; 122(10):946-8. PubMed ID: 20733094
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary artery restenosis: a paradigm of current treatment approaches.
    Kiernan TJ; Kiernan GD; Yan BD
    Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter by Kereiakes et al regarding article, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern".
    Kereiakes DJ; Mauri L; Kuntz RE
    Circulation; 2007 Oct; 116(16):e389; author reply e390. PubMed ID: 17938296
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter by Agostini et al regarding article, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern".
    Agostoni P; Sangiorgi GM; Biondi-Zoccai GG
    Circulation; 2007 Oct; 116(16):e388; author reply e390. PubMed ID: 17938295
    [No Abstract]   [Full Text] [Related]  

  • 14. [Late stent thrombosis thirteen months after drug-eluting stent implantation].
    Sacha J; Wester A; Pluta W
    Kardiol Pol; 2008 Jan; 66(1):78-80; discussion 84-5. PubMed ID: 18266191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label use of drug-eluting stents putting it in perspective.
    Grines CL
    J Am Coll Cardiol; 2008 Feb; 51(6):615-7. PubMed ID: 18261679
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
    Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
    J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.
    Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2007 Nov; 50(21):2037-8. PubMed ID: 18021869
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary revascularisation following intracoronary brachytherapy.
    Sabaté M
    EuroIntervention; 2009 May; 5 Suppl D():D121-6. PubMed ID: 19736060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.